// App-Quantinova.ai

e16005 : A pilot study comparing circulation tumor cells (CTC) detection by AdnaTest prostate assay to CellSearch in patients (pts) with castration resistant prostate cancer (CRPC).

Researchers

Presenter

  • Aliaksandra Samoila

Principal Investigators

  • Diogo Assed Bastos

  • Amrita Herkal

  • Chintan Patel

  • Kristen Rebecca Curtis

  • Nicole A Schreiber

  • Aseem Anand

  • Martin Fleisher

  • Howard I. Scher

  • Daniel Costin Danila

Medical Centers

  • Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY

  • Memorial Sloan Kettering Cancer Center, Port Washington, NY

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Urology

Disease

  • Metastatic castration-resistant prostate cancer

Biomarkers

  • Circulating tumor cells

  • Prostate specific antigen

  • Epidermal growth factor receptor

  • Epithelial Cell Adhesion Molecule

  • Folate Hydrolase 1

  • Human epidermal growth factor receptor 2

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved